• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清白细胞介素-38 水平与非酒精性脂肪性肝病中的胰岛素抵抗、肝损伤和脂质相关。

Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease.

机构信息

Department of Biochemistry and Molecular Biology, School of Medicine, Jiujiang University, 17# Lufeng Road, Jiujiang, 332000, Jiangxi Province, China.

Department of Clinical Laboratory, Jiujiang NO.1 People's Hospital, 48# The South of Taling Road, Jiujiang, 332000, Jiangxi Province, China.

出版信息

Lipids Health Dis. 2022 Aug 10;21(1):70. doi: 10.1186/s12944-022-01676-0.

DOI:10.1186/s12944-022-01676-0
PMID:35948957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9364532/
Abstract

BACKGROUND

Insulin resistance, liver injury and dyslipidemia are reported in non-alcoholic fat liver disease (NAFLD) patients. Interleukin (IL)-38 may take part in the pathophysiology of insulin resistance. Nevertheless, the function of IL-38 in NAFLD is unknown. Herein, we determined whether serum IL-38 level might be utilised as a biochemical marker for diagnosing NAFLD.

METHODS

NAFLD patients and healthy participants (n = 91 each) were enrolled. Circulating serum IL-38 levels were detected using enzyme-linked immunosorbent assay. Other metabolic and inflammatory indices related to NAFLD were also assessed.

RESULTS

Patients with NAFLD had higher serum IL-38 levels than healthy individuals. Significantly higher serum IL-38 levels were found in patients with severe and moderate NAFLD than in patients with mild NAFLD. IL-38 showed a significant correlation with parameters of insulin resistance, inflammation, and liver enzyme in NAFLD cases. Anthropometric, insulin resistance, inflammatory parameters, lipids and frequency of NAFLD showed significant differences among the serum IL-38 level tertiles. Participants in the 2nd and 3rd tertiles of serum IL-38 levels had a greater risk of NAFLD than those in the 1st tertile. Furthermore, IL-38 ROC curve showed a high area under ROC with 0.861.

CONCLUSIONS

It is possible for serum IL-38 to be a biomarker for NAFLD.

摘要

背景

胰岛素抵抗、肝损伤和血脂异常在非酒精性脂肪性肝病(NAFLD)患者中均有报道。白细胞介素(IL)-38可能参与胰岛素抵抗的病理生理学过程。然而,IL-38在 NAFLD 中的作用尚不清楚。在此,我们确定血清 IL-38 水平是否可作为诊断 NAFLD 的生化标志物。

方法

纳入 91 例 NAFLD 患者和 91 例健康对照者。采用酶联免疫吸附试验检测循环血清 IL-38 水平。同时评估与 NAFLD 相关的其他代谢和炎症指标。

结果

与健康对照者相比,NAFLD 患者血清 IL-38 水平更高。中、重度 NAFLD 患者的血清 IL-38 水平明显高于轻度 NAFLD 患者。IL-38 与 NAFLD 患者的胰岛素抵抗、炎症和肝酶参数呈显著相关。血清 IL-38 水平三分位组间的人体测量学、胰岛素抵抗、炎症参数、血脂以及 NAFLD 频率均存在显著差异。血清 IL-38 水平处于第 2 分位和第 3 分位的患者发生 NAFLD 的风险高于第 1 分位。此外,IL-38 的 ROC 曲线显示其具有 0.861 的高 ROC 曲线下面积。

结论

血清 IL-38 可能成为 NAFLD 的一种生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f1/9364532/c2d574cee03b/12944_2022_1676_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f1/9364532/730296b413a3/12944_2022_1676_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f1/9364532/2677a1b90d01/12944_2022_1676_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f1/9364532/c2d574cee03b/12944_2022_1676_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f1/9364532/730296b413a3/12944_2022_1676_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f1/9364532/2677a1b90d01/12944_2022_1676_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71f1/9364532/c2d574cee03b/12944_2022_1676_Fig3_HTML.jpg

相似文献

1
Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease.血清白细胞介素-38 水平与非酒精性脂肪性肝病中的胰岛素抵抗、肝损伤和脂质相关。
Lipids Health Dis. 2022 Aug 10;21(1):70. doi: 10.1186/s12944-022-01676-0.
2
Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.慢性斑块状银屑病患者白细胞介素水平与非酒精性脂肪性肝病:一项分析性病例对照研究
Indian J Dermatol. 2023 Jul-Aug;68(4):377-384. doi: 10.4103/ijd.ijd_1015_22.
3
Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.非酒精性脂肪性肝病患者的葡萄糖稳态、胰岛素抵抗及炎症生物标志物:补充普通小球藻的有益作用:一项双盲安慰剂对照随机临床试验
Clin Nutr. 2017 Aug;36(4):1001-1006. doi: 10.1016/j.clnu.2016.07.004. Epub 2016 Jul 19.
4
Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease.作为一种新型标志物,联用Asprosin 和脂联素用于诊断非酒精性脂肪肝疾病。
Cytokine. 2020 Oct;134:155184. doi: 10.1016/j.cyto.2020.155184. Epub 2020 Jul 6.
5
[Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].非酒精性脂肪性肝病患者肠道微生物群与生化指标的相关性分析
Zhonghua Gan Zang Bing Za Zhi. 2019 May 20;27(5):369-375. doi: 10.3760/cma.j.issn.1007-3418.2019.05.009.
6
Decreased serum neuregulin 4 levels associated with non-alcoholic fatty liver disease in children with obesity.肥胖儿童非酒精性脂肪性肝病与血清神经调节蛋白4水平降低有关。
Clin Obes. 2019 Feb;9(1):e12289. doi: 10.1111/cob.12289. Epub 2018 Nov 8.
7
Phenotype, Body Composition, and Prediction Equations (Indian Fatty Liver Index) for Non-Alcoholic Fatty Liver Disease in Non-Diabetic Asian Indians: A Case-Control Study.非糖尿病亚洲印度人非酒精性脂肪性肝病的表型、身体成分及预测方程(印度脂肪肝指数):一项病例对照研究
PLoS One. 2015 Nov 24;10(11):e0142260. doi: 10.1371/journal.pone.0142260. eCollection 2015.
8
Association between serum interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD).血清白细胞介素 (IL)-12 水平与非酒精性脂肪性肝病 (NAFLD) 严重程度的关系。
Rom J Intern Med. 2021 Mar 5;59(1):66-72. doi: 10.2478/rjim-2020-0029. Print 2021 Mar 1.
9
Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease.血清 IL-27 水平在甲状腺功能减退症患者中升高,与非酒精性脂肪性肝病的发生呈负相关。
Front Endocrinol (Lausanne). 2023 Aug 2;14:1173826. doi: 10.3389/fendo.2023.1173826. eCollection 2023.
10
Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.促炎细胞因子、脂肪因子和氧化应激与胰岛素抵抗和非酒精性脂肪性肝病的关系。
Indian J Med Res. 2012 Aug;136(2):229-36.

引用本文的文献

1
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.免疫系统的代谢调控在健康和疾病中的作用:机制与干预措施。
Signal Transduct Target Ther. 2024 Oct 9;9(1):268. doi: 10.1038/s41392-024-01954-6.
2
Gut microbiota in insulin resistance: a bibliometric analysis.胰岛素抵抗中的肠道微生物群:一项文献计量分析
J Diabetes Metab Disord. 2024 Feb 14;23(1):173-188. doi: 10.1007/s40200-023-01342-x. eCollection 2024 Jun.
3
Interleukin-38 and Insulin Resistance.白细胞介素-38 与胰岛素抵抗。

本文引用的文献

1
Low serum interleukin-38 levels in patients with Graves' disease and Hashimoto's thyroiditis.Graves 病和桥本甲状腺炎患者血清白细胞介素-38 水平降低。
J Clin Lab Anal. 2022 Jan;36(1):e24101. doi: 10.1002/jcla.24101. Epub 2021 Nov 19.
2
The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases.白细胞介素-38在自身免疫性疾病中的病理机制及潜在应用
Front Pharmacol. 2021 Sep 2;12:732790. doi: 10.3389/fphar.2021.732790. eCollection 2021.
3
Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression.
Endocr Metab Immune Disord Drug Targets. 2024;24(6):611-616. doi: 10.2174/1871530323666230911114150.
血浆细胞因子、炎症和肝损伤之间的串扰作为监测 NAFLD 进展的新策略。
Front Immunol. 2021 Aug 10;12:708959. doi: 10.3389/fimmu.2021.708959. eCollection 2021.
4
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.当前和新兴的非酒精性脂肪性肝病生物标志物和影像学手段:临床和研究应用。
Clin Ther. 2021 Sep;43(9):1505-1522. doi: 10.1016/j.clinthera.2021.07.012. Epub 2021 Aug 13.
5
IL-38 as an early predictor of the ischemic stroke prognosis.IL-38 作为缺血性脑卒中预后的早期预测指标。
Cytokine. 2021 Oct;146:155626. doi: 10.1016/j.cyto.2021.155626. Epub 2021 Jun 19.
6
Higher Circulating Concentration of Interleukin-38 in Patients with Knee Osteoarthritis: Its Association with Disease Severity.膝关节骨关节炎患者循环白细胞介素-38 浓度升高:与疾病严重程度的关系。
Iran J Allergy Asthma Immunol. 2021 Feb 11;20(1):114-119. doi: 10.18502/ijaai.v20i1.5418.
7
Management of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的管理
BMJ. 2021 Jan 18;372:m4747. doi: 10.1136/bmj.m4747.
8
Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes.健康衰老和 2 型糖尿病患者白细胞介素-38 的血浆水平。
Diabetes Res Clin Pract. 2021 Jan;171:108585. doi: 10.1016/j.diabres.2020.108585. Epub 2020 Dec 10.
9
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017.非酒精性脂肪性肝病所致残疾负担日益加重:2007 - 2017年全球疾病负担数据
Hepatol Commun. 2020 Sep 14;4(12):1769-1780. doi: 10.1002/hep4.1599. eCollection 2020 Dec.
10
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.非酒精性脂肪性肝病(NAFLD):从发病机制到人类治疗理念。
Mol Metab. 2021 Aug;50:101122. doi: 10.1016/j.molmet.2020.101122. Epub 2020 Nov 19.